AC Immune (ACIU) Free Cash Flow (2015 - 2025)

AC Immune (ACIU) has 11 years of Free Cash Flow data on file, last reported at -$20.8 million in Q4 2025.

• On a quarterly basis, Free Cash Flow fell 402.45% year-over-year to -$20.8 million in Q4 2025; TTM through Mar 2026 was -$63.2 million, a 225.27% decrease from a year earlier, with the FY2025 full-year figure at -$84.5 million, down 211.47% from the prior year.
• Free Cash Flow for Q4 2025 stood at -$20.8 million, up from -$23.3 million in the prior quarter.
• Over the last five years, Free Cash Flow for ACIU reached as high as $80.8 million in Q2 2024 and fell as low as -$24.6 million in Q4 2021.
• Historically, Free Cash Flow has averaged -$11.5 million across 5 years, with a median of -$18.1 million in 2023.
• Across the five-year window, Free Cash Flow jumped 617.89% in 2024 and plunged 1548.68% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at -$24.6 million in 2021, then advanced by 16.54% to -$20.6 million in 2022, then increased by 11.15% to -$18.3 million in 2023, then jumped by 137.64% to $6.9 million in 2024, then plunged by 402.45% to -$20.8 million in 2025.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$20.8 million in Q4 2025, -$23.3 million in Q3 2025, and -$19.1 million in Q2 2025.